Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients

Completed · Phase 3

Conditions studied: Glaucoma, Ocular Hypertension

In brief

This study evaluates the safety of brimonidine/timolol fixed combination in glaucoma or ocular hypertension patients

Key facts

Study ID

NCT00651612

Run by

Allergan

People needed

604

Starts

2005-11-01

Expected to finish

2007-01-01

Last updated by the study team

2008-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of ocular hypertension or glaucoma
• Patient requires IOP-lowering therapy in both eyes

You may not qualify if…

• Uncontrolled medical conditions
• Contraindication to β-adrenoceptor antagonist therapy or brimonidine therapy

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.